| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $212,049 | 5 | 36 |
Sells | $946,387 | 9 | 64 |
| Errico Thomas J. | director | 3 | $158,206 | 0 | $0 | $158,206 |
| Fox Michael | See Remarks | 1 | $49,004 | 0 | $0 | $49,004 |
| Goldberger Daniel S | Chief Executive Officer | 1 | $4,840 | 2 | $640,753 | $-635,913 |
| Lev Joshua S. | Chief Financial Officer | 0 | $0 | 7 | $305,634 | $-305,634 |
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many …
Over the last 12 months, insiders at electroCore, Inc. have bought $212,049 and sold $946,387 worth of electroCore, Inc. stock.
On average, over the past 5 years, insiders at electroCore, Inc. have bought $264,895 and sold $946,387 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Errico Thomas J. (director) — $158,206. Fox Michael (See Remarks) — $49,004. Goldberger Daniel S (Chief Executive Officer) — $4,840.
The last purchase of 5,000 shares for transaction amount of $49,082 was made by Errico Thomas J. (director) on 2026‑09‑14.
| 2026-09-14 | Errico Thomas J. | director | 5,000 0.0535% | $9.82 | $49,082 | -1.79% | ||
| 2026-09-11 | Fox Michael | See Remarks | 5,000 0.0542% | $9.80 | $49,004 | +0.42% | ||
| 2026-08-25 | Sale | Lev Joshua S. | CFO and Interim President | 3,000 0.0329% | $9.36 | $28,080 | +0.42% | |
| 2026-08-24 | Sale | Lev Joshua S. | CFO and Interim President | 5,000 0.0544% | $9.88 | $49,400 | -1.55% | |
| 2026-08-21 | Sale | Lev Joshua S. | CFO and Interim President | 12,000 0.124% | $10.22 | $122,640 | -9.60% | |
| 2026-08-13 | Errico Thomas J. | director | 5,000 0.0527% | $9.85 | $49,272 | -3.12% | ||
| 2026-05-28 | Sale | Lev Joshua S. | CFO and Interim President | 6,667 0.0783% | $9.00 | $60,003 | -2.87% | |
| 2026-05-22 | Sale | Lev Joshua S. | CFO and Interim President | 3,000 0.0392% | $6.50 | $19,500 | +34.78% | |
| 2026-05-21 | Errico Thomas J. | director | 9,992 0.1204% | $5.99 | $59,852 | +49.83% | ||
| 2026-04-23 | Sale | Goldberger Daniel S | Former Officer & Director | 80,000 1.0889% | $6.80 | $544,000 | +35.44% | |
| 2026-04-10 | Sale | Goldberger Daniel S | Former Officer and Director | 16,072 0.18% | $6.02 | $96,753 | +34.87% | |
| 2025-12-04 | Sale | Lev Joshua S. | Chief Financial Officer | 2,500 0.0319% | $5.05 | $12,625 | +37.17% | |
| 2025-12-02 | Goldberger Daniel S | Chief Executive Officer | 1,000 0.0127% | $4.84 | $4,840 | +42.95% | ||
| 2025-11-12 | Sale | Lev Joshua S. | Chief Financial Officer | 2,166 0.0287% | $6.18 | $13,386 | +10.15% | |
| 2025-08-11 | Goldberger Daniel S | Chief Executive Officer | 1,000 0.0129% | $4.23 | $4,230 | +40.84% | ||
| 2025-08-11 | Errico Thomas J. | director | 15,000 0.2051% | $4.47 | $67,050 | +40.84% | ||
| 2025-05-23 | GANDOLFO JOHN P | director | 1,800 0.0245% | $5.01 | $9,018 | +10.26% | ||
| 2025-05-12 | Errico Thomas J. | director | 10,000 0.1335% | $4.77 | $47,735 | +11.41% | ||
| 2025-03-17 | Goldberger Daniel S | Chief Executive Officer | 1,000 0.0145% | $8.59 | $8,590 | -35.11% | ||
| 2025-03-17 | Errico Thomas J. | director | 6,000 0.0818% | $8.10 | $48,585 | -35.11% |
| Errico Thomas J. | director | 363904 4.0363% | $2.63M | 16 | 0 | <0.0001% |
| Goldberger Daniel S | Former Officer & Director | 211471 2.3455% | $1.53M | 21 | 2 | +18.81% |
| Fox Michael | See Remarks | 130000 1.4419% | $939,900.00 | 1 | 0 | |
| Merck Global Health Innovation Fund, LLC | 10 percent owner | 3346032 37.1126% | $24.19M | 1 | 0 | <0.0001% |
| Errico Joseph P | director | 2724841 30.2227% | $19.7M | 10 | 6 | +12.97% |
| TULLIS JAMES L L | director | 1764705 19.5733% | $12.76M | 3 | 0 | |
| Moody Trevor J | 423455 4.6968% | $3.06M | 3 | 0 | <0.0001% | |
| Amato Francis R. | Chief Executive Officer | 358831 3.98% | $2.59M | 1 | 0 | <0.0001% |
| Staats Peter S. | Chief Medical Officer | 154636 1.7152% | $1.12M | 1 | 0 | <0.0001% |
| GANDOLFO JOHN P | director | 69087 0.7663% | $499,499.01 | 4 | 0 | <0.0001% |
| POSNER BRIAN M | Chief Financial Officer | 22437 0.2489% | $162,219.51 | 4 | 1 | <0.0001% |
| COX CARRIE SMITH | director | 21000 0.2329% | $151,830.00 | 3 | 0 | <0.0001% |
| Increased Positions | 12 | +34.29% | 259,667 | +35.65% |
| Decreased Positions | 11 | -31.43% | 52,240 | -7.17% |
| New Positions | 6 | New | 231,426 | New |
| Sold Out Positions | 5 | Sold Out | 258 | Sold Out |
| Total Postitions | 36 | +2.86% | 935,854 | +28.48% |
| Vanguard Group Inc | $1,062.00 | 2.92% | 233,473 | +1,140 | +0.49% | 2025-09-30 |
| Renaissance Technologies Llc | $456.00 | 1.25% | 100,286 | -80,400 | -44.5% | 2025-09-30 |
| International Assets Investment Management, Llc | $350.00 | 0.96% | 77,020 | 0 | 0% | 2025-09-30 |
| Geode Capital Management, Llc | $317.00 | 0.87% | 69,629 | +3,087 | +4.64% | 2025-09-30 |
| Jaffetilchin Investment Partners, Llc | $222.00 | 0.61% | 48,763 | +6,980 | +16.7% | 2025-09-30 |
| Wealthspire Advisors, Llc | $216.00 | 0.59% | 47,498 | 0 | 0% | 2025-09-30 |
| Hightower Advisors, Llc | $161.00 | 0.44% | 35,342 | 0 | 0% | 2025-09-30 |
| State Street Corp | $121.00 | 0.33% | 26,518 | 0 | 0% | 2025-09-30 |
| Blackrock, Inc. | $118.00 | 0.33% | 25,964 | -1,252 | -4.6% | 2025-09-30 |
| Two Sigma Investments, Lp | $112.00 | 0.31% | 24,603 | +4,231 | +20.77% | 2025-09-30 |